Journal article
Repurposing Renin–Angiotensin System Drugs for the Treatment of Audiovestibular Disorders
Journal of clinical medicine, Vol.15(2), 743
01/16/2026
DOI: 10.3390/jcm15020743
PMID: 41598680
Abstract
Audiovestibular disorders arising from the inner ear (e.g., hearing loss, tinnitus, vertigo) are widely prevalent in the United States. Yet, medical treatments targeting the underlying pathology of these disorders remain scarce. The practice of repurposing FDA-approved drugs for new therapeutic indications has become increasingly common, offering a lower risk route to treatment development with fewer barriers to implementation, as safety profiles are already established. The renin–angiotensin system (RAS) is well known for its role in blood pressure and fluid balance, and its overactivation induces acute and chronic inflammation and oxidative stress. This review discusses existing evidence and proposed otoprotective mechanisms of RAS inhibition, specifically using angiotensin II type 1 receptor blockers (ARBs), which support the repurposing of these medications as novel treatments to affect the inner ear pathologies that underlay hearing loss, tinnitus, and vertigo.
Details
- Title: Subtitle
- Repurposing Renin–Angiotensin System Drugs for the Treatment of Audiovestibular Disorders
- Creators
- Grant Podhajsky - University of Iowa, OtolaryngologyKiran S. Marla - University of IowaAlec P. Marticoff - University of IowaKenny Nguyen - University of Arkansas for Medical SciencesTanner Kempton - University of IowaSepehr Salehpour - University of Iowa, OtolaryngologyCaden Duffy - University of IowaDouglas M. Bennion - University of Iowa
- Resource Type
- Journal article
- Publication Details
- Journal of clinical medicine, Vol.15(2), 743
- DOI
- 10.3390/jcm15020743
- PMID
- 41598680
- ISSN
- 2077-0383
- eISSN
- 2077-0383
- Publisher
- MDPI
- Grant note
- Univ of Iowa Department of Otolaryngology: Schilling Resident Research Grant
- Language
- English
- Date published
- 01/16/2026
- Academic Unit
- Otolaryngology
- Record Identifier
- 9985130217902771
Metrics
3 Record Views